The Efficacy and Safety of Calcineurin Inhibitors in Inducing and Maintaining Clinical Remission in IBD Patients Commencing Vedolizumab

被引：0
|
作者：
Christensen, Britt
Goeppinger, Sarah R.
Colman, Ruben J.
Siddiqui, Dania
Yarur, Andres
Hirsch, Ayal
Bochenek, Ashley A.
Wichmann, Alana
Sakuraba, Atsushi
Cohen, Russell D.
Rubin, David T.
机构：
来源：
GASTROENTEROLOGY | 2015年 / 148卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1340
引用
收藏
页码：S866 / S866
页数：1
相关论文
共 50 条
  • [1] Calcineurin inhibitors are safe and effective for induction of remission in patients commencing vedolizumab for IBD
    Christensen, B.
    Goeppinger, S. R.
    Colman, R.
    Siddiqui, D.
    Yarur, A.
    Hirsch, A.
    Bochenek, A. A.
    Wichmann, A.
    Sakuraba, A.
    Cohen, R.
    Rubin, D. T.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S281 - S281
  • [2] EFFICACY OF CALCINEURIN INHIBITORS DURING INDUCTION AND MAINTENANCE OF REMISSION WITH VEDOLIZUMAB IN IBD
    Kassim, Olufemi
    Micic, Dejan
    Christensen, Britt
    Pekow, Joel R.
    Sakuraba, Atsushi
    Dalal, Sushila
    Kahn, Stacy A.
    Rubin, David T.
    Cohen, Russell D.
    GASTROENTEROLOGY, 2017, 152 (05) : S405 - S405
  • [3] Can calcineurin inhibitors induce a durable remission that is maintained with vedolizumab in IBD?
    Kassim, O.
    Micic, D.
    Christensen, B.
    Pekow, J.
    Sakuraba, A.
    Dalal, S.
    Rubin, D.
    Cohen, R.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S309 - S309
  • [4] Vedolizumab Efficacy and Safety in a Tertiary Care IBD Clinical Practice
    Vivio, Emily
    Kanuri, Navya D.
    Dey, Neelendu
    Chen, Chien-Huan
    Gutierrez, Alexandra
    Ciorba, Matthew A.
    GASTROENTEROLOGY, 2015, 148 (04) : S871 - S872
  • [5] Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative Colitis
    Pellet, Gauthier
    Stefanescu, Carmen
    Carbonnel, Franck
    Peyrin-Biroulet, Laurent
    Roblin, Xavier
    Allimant, Christophe
    Nachury, Maria
    Nancey, Stephane
    Filippi, Jerome
    Altwegg, Romain
    Brixi, Hedia
    Fotsing, Ginette
    de Rosamel, Laure
    Shili, Sarah
    Laharie, David
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (03) : 494 - 501
  • [6] Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease
    Christensen, Britt
    Gibson, Peter R.
    Micic, Dejan
    Colman, Ruben J.
    Goeppinger, Sarah R.
    Kassim, Olufemi
    Yarur, Andres
    Weber, Christopher R.
    Cohen, Russell D.
    Rubin, David T.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (03) : 486 - 493
  • [7] MAINTENANCE LEVELS OF VEDOLIZUMAB DO NOT CORRELATE WITH CLINICAL REMISSION IN IBD PATIENTS
    Tessolini, Jenna M.
    Bajaj, Girish
    Zezos, Petros
    O'Connell, Jim W.
    Huang, Vivian
    Croitoru, Kenneth
    Steinhart, A. Hillary
    Kelly, Orlaith
    O'Toole, Aoibhlinn
    Kevans, David
    Silverberg, Mark S.
    GASTROENTEROLOGY, 2019, 156 (06) : S1140 - S1140
  • [8] Mirikizumab for inducing and maintaining clinical remission in ulcerative colitis
    Hindson, Jordan
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2023, 20 (09) : 559 - 559
  • [9] Mirikizumab for inducing and maintaining clinical remission in ulcerative colitis
    Jordan Hindson
    Nature Reviews Gastroenterology & Hepatology, 2023, 20 : 559 - 559
  • [10] Vedolizumab Safety Profile in Treatment of Elderly IBD Patients
    Marnoy, Zachary
    Grossberg, Laurie
    Hartwell, Nathan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S1589 - S1589
12345